Deira Trading Company


Novartis has boosted its 2024 outlook for a second time this year, thanks to strong sales for some of its biggest drugs used to treat heart failure and other ailments.

Leave a Reply

Your email address will not be published. Required fields are marked *

Source: CurrencyRate